K. Nishioka

发表

Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation.

Masahiko Kushida, T. Sukata, S. Uwagawa, 2009, Toxicological sciences : an official journal of the Society of Toxicology.

Identification and in silico prediction of metabolites of the model compound, tebufenozide by human CYP3A4 and CYP2C19.

M. Akamatsu, H. Miyagawa, S. Ikushiro, 2015, Bioorganic & medicinal chemistry.

Synthesis and properties of butatrienes containing a bisdehydro[13]annulene system as terminal groups

M. Iyoda, M. Oda, K. Nishioka, 1983 .

14C‐labeling of a tetrahydroacridine, a novel CNS‐selective cholinesterase inhibitor

K. Nishioka, H. Kanamaru, T. Kamada, 1992 .

Discovery of potent and orally bioavailable 17β-hydroxysteroid dehydrogenase type 3 inhibitors.

K. Harada, S. Okada, J. Abe, 2012, Bioorganic & medicinal chemistry.

Identification of oxazolidinediones and thiazolidinediones as potent 17β-hydroxysteroid dehydrogenase type 3 inhibitors.

K. Harada, H. Kubo, A. Tanaka, 2012, Bioorganic & medicinal chemistry letters.

Coumarins as novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer.

K. Harada, H. Kubo, Y. Tomigahara, 2010, Bioorganic & medicinal chemistry letters.

In vitro metabolism of trans-permethrin and its major metabolites, PBalc and PBacid, in humans.

H. Kaneko, K. Nishioka, T. Takaku, 2011, Journal of agricultural and food chemistry.

Coumarins as Novel 17β‐Hydroxysteroid Dehydrogenase Type 3 Inhibitors for Potential Treatment of Prostate Cancer.

K. Harada, H. Kubo, Y. Tomigahara, 2010 .

14C-LABELING OF A NOVEL CARBAPENEM ANTIBIOTIC SM-7338

K. Nishioka, H. Kanamaru, 1991 .

Comparative Metabolic Responses to Halogenated Anaesthetics

K. Nishioka, H. Arandia, A. Dobkin, 1972, Acta anaesthesiologica Scandinavica.

Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes.

B. Lake, S. Uwagawa, S. Kawamura, 2009, Toxicology.

Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.

M. Suzui, S. Uwagawa, K. Sumida, 2013, Carcinogenesis.

14C-labeling of a novel anxiolytic agent tandospirone

K. Nishioka, H. Kanamaru, 1992 .

14C‐labeling of a novel prostacyclin I1 derivative, SM‐10902

M. Kurosawa, K. Nishioka, H. Kanamaru, 1997 .